Treatment of Chronic Active Antibody-mediated Rejection With Pulse Steroids, IVIG, With or Without Rituximab is Associated With Increased Risk of Pneumonia

BACKGROUND. The risk of infection associated with specific treatments of chronic active antibody-mediated rejection (cAMR) after kidney transplantation remains unknown. METHODS. This was a single-center study of kidney transplant recipients treated with pulse steroids, intravenous immunoglobulin (IV...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Transplant Direct
Main Authors: Joachim, Emily, Parajuli, Sandesh, Swanson, Kurtis J., Aziz, Fahad, Garg, Neetika, Mohamed, Maha, Mandelbrot, Didier, Djamali, Arjang
Format: Artigo
Jezik:Inglês
Izdano: Lippincott Williams & Wilkins 2020
Teme:
Kidney Transplantation
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7738046/
https://ncbi.nlm.nih.gov/pubmed/33335983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000001080
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki